Vaccine Therapy in Treating Patients With Metastatic Cancer

Completed · Phase 2

Conditions studied: Melanoma (Skin), Unspecified Adult Solid Tumor, Protocol Specific

In brief

RATIONALE: Vaccines made from a peptide may make the body build an immune response and kill tumor cells. PURPOSE: Randomized phase II trial to study the effectiveness of vaccine therapy in treating patients who have metastatic cancer.

Key facts

Study ID

NCT00021164

Run by

National Cancer Institute (NCI)

Starts

2001-05-01

Expected to finish

2004-05-01

Last updated by the study team

2013-06-19

Who can join

Age: 16 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support — Bethesda, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.